Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
7.71
-0.07 (-0.90%)
At close: Mar 27, 2026
HKG:3613 Market Cap
HKG:3613 has a market cap or net worth of 6.45 billion as of March 27, 2026. Its market cap has decreased by -5.98% in one year.
Market Cap
6.45B
Enterprise Value
4.47B
Revenue
1.51B
Ranking
n/a
PE Ratio
16.25
Stock Price
7.71
Market Cap Chart
Since May 7, 2013, HKG:3613's market cap has increased from 5.22B to 6.45B, an increase of 23.55%. That is a compound annual growth rate of 1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.45B | -8.87% |
| Dec 31, 2025 | 7.08B | -3.64% |
| Dec 31, 2024 | 7.35B | -27.68% |
| Dec 29, 2023 | 10.16B | 5.93% |
| Dec 30, 2022 | 9.59B | -14.61% |
| Dec 31, 2021 | 11.23B | 64.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sihuan Pharmaceutical Holdings Group | 12.35B |
| Ab&B Bio-Tech CO., LTD. JS | 12.14B |
| Shandong Xinhua Pharmaceutical Company | 9.77B |
| Luye Pharma Group | 9.63B |
| CF PharmTech | 9.40B |
| China Traditional Chinese Medicine Holdings Co. | 9.17B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.34B |
| SSY Group | 6.96B |